Veracyte, Inc. (VCYT) SEC Filing 8-K Material Event for the period ending Friday, October 26, 2018

Veracyte, Inc.

CIK: 1384101 Ticker: VCYT

View differences made from one to another to evaluate Veracyte, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Veracyte, Inc..


Assess how Veracyte, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Veracyte, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: VCYT
CIK: 1384101
Form Type: 8-K Corporate News
Accession Number: 0001384101-18-000074
Submitted to the SEC: Fri Oct 26 2018 6:29:15 AM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Friday, October 26, 2018
Industry: Medical Laboratories
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: